HIV Vaccine Trials Unit (HVTU)
HVTN 906 - An observational study of women at high risk of becoming HIV infected. (For more information, click here.)
HVTN 080 - A Phase I study to evaluate the safety of a new, experimental HIV vaccine developed at the University of Pennsylvania known as PENNVAX (same product as HVTN 070). The vaccine will be administered in this study with a novel technique known as electroporation.
To make an appointment, or inquire further about our services, please call: 1-866-448-7366.